The statistical literature on assessing the accuracy of risk factors or disease markers as diagnostic tests deals almost exclusively with settings where the test, , is measured concurrently with disease status ¡ . In practice, however, disease status may vary over time and there is often a time lag between when the marker is measured and the occurrence of disease. One example concerns the Framingham Risk Score as a marker for the future risk of cardiovascular events, events that occur after the score is ascertained. To evaluate such a marker, one needs to take the time lag into account since the predictive accuracy may be higher when the marker is measured closer to the time of disease occurrence. We therefore consider inference for sensitivity and specificity functions that are defined as functions of time. Semi-parametric regression models are proposed. Data from a cohort study are used to estimate model parameters. One issue that arises in practice is that event times may be censored. In this research, we extend in several respects the work by Leisenring, Pepe and Longton (1997) that dealt only with parametric models for binary tests and uncensored data. We propose semi-parametric models that accommodate continuous tests and censoring. Asymptotic distribution theory for parameter estimates is developed and procedures for making statistical inference are evaluated with simulation studies. We illustrate our methods with data from the Cardiovascular Health Study, relating the Framingham risk score measured at enrollment to subsequent risk of cardiovascular events.
INTRODUCTION
The use of clinical and laboratory data to predict future patient events is a very popular idea in medicine at present. Biomarkers are under development to detect cancer before onset of clinical disease (Pepe et al, 2001 ). Gene expression profiles of tumor tissue promise to be predictive of survival in cancer patients (Veer et al, 2002) . Clinical scores, such as the Framingham Risk Score (Wilson et al, 1998) , are considered predictive of myocardial infarction and stroke. It is critical to evaluate the sensitivity and specificity of such predictors or markers before adopting them for use in clinical practice.
The literature on evaluating the accuracy of a marker, predictor or diagnostic test result, , deals primarily with settings where is measured concurrently with the gold standard disease variable However, the definitions in (1R 1) and (1R 2) lead to more straightforward regression modeling procedures and are easier to interpret as functions of time than their cumulative incidence based counterparts. For extensive discussion see Pepe (2003, pages 259-65) . Moreover, we can calculate (1R 3) and (1R 4) from (1R 1) and (1R 2) with knowledge of the event time distribution. Thus we concentrate on ( 1R 1) and (1R 2) here initially, and return to (1R 3) and (1R 4) in the example.
In this paper we consider models for the time dependent ¢ TPR FPR¥ functions in (1R 1) and (1R 2) and procedures to make inference about them from prospective cohort studies. The marker may be measured at multiple times for a subject, covariates ¦ that affect the true and false positive rates may be available and the event time 0 can be right censored. We extend the marginal regression modeling approach of Leisenring, Pepe and Longton (1997) which deals only with binary markers and uncensored failure times. We develop our method in a simplified setting in the next section. The more general setting is discussed in section 3. Results from simulation studies described in section 4
suggest that the procedures work well in finite samples when the assumptions hold. In the second part of section 4 we apply the methods to data from the Cardiovascular Health Study, a prospective cohort study of older adults (Fried et al, 1991) . We investigate the sensitivity (TPR) and specificity
(1-FPR) of the Framingham risk score as a marker for future cardiovascular events in this population.
As expected, we show that the score is better at discriminating short term than long term risk and that it works better in females than in males. However, the score is not a very accurate predictor in any subgroup studied. We close in section 5 with a discussion of alternative approaches to the evaluation of markers for event time data.
(2R 1) and to supplement it with the FPR model (2R 2). This is analogous to the approach taken by Hogan and Laird (1997) in the mixture model framework where they reserved a multinomial category for subjects who have not yet experienced an event by the end of the study.
Denote all the parameters in (2R 1) and (2R 2) by g g g h C
. Note that (2R 1) models the distribution of conditional on The likelihood of the data is therefore (Fleming and Harrington, 1991) .
Plugging in the estimated survival function to (2R 4), we obtain approximate conditional probabilities,
c an be estimated by maximizing the approximated likelihood function, or equivalently, as the solution to the approximated score equation,
We note that other regression models for and does not rely on the proportional hazards model assumption.
3R 1 Model Assumptions
We now generalize to a continuous marker, , and allow measurements at various times
is the time lag between the measurement time and the occurrence of the event. Consider the following marginal probability models: 
3R 2 Estimating the Model Components
6 5 is a pre-specified non-negative weight, 
is some increasing function that can depend on the data but converges asymptotically to a deterministic function
. The basic idea then is to solve (3R 3) and (3R 4) simultaneously to estimate the parameters in the models (3R 1) and (3R 2).
Observe that we now include in the estimating equations a weighting factor as in the binary case assuming a proportional hazards model (2R 5). Then we solve (3R 3) and (3R 4) using the weight functions
3R 3 Inference in Large Samples
We show in appendix A that as:
To obtain pointwise and simultaneous confidence intervals for the TPR and FPR functions, we show in appendix B that the process
is defined in (B.1). This allows us to approximate the distribution of the process
¥ using re-sampling techniques (Parzen, Wei and Ying, 1994) in practice. This technique avoids the need to derive explicit analytic expressions for variance-covariance processes, which seem intractable in our setting. Moreover, relative to other re-sampling methods such as the bootstrap, the computational burden is minimal. A detailed description of the procedure for constructing confidence bands based on the re-sampling method can be found in Cai & Pepe (2002) .
SIMULATION STUDIES AND EXAMPLE 4R 1 Simulation Studies
Simulation studies were performed to examine the finite sample properties of the estimation procedures proposed in the previous sections and to investigate the impact of , we find that the estimates are almost always more precise than those calculated with
§ #
. See Cai et al (2003) for details on simulation results.
To choose an optimal weighting of censored data in practice, one could use an "optimization procedure" to minimize the total mean squared error as a predictor for cardiovascular events. The FR-score is a widely used clinical prediction score used to quantify risk for cardiovascular events (Grundy et al, 1998 (Grundy et al, , 2001 ). It includes information on age, cigarette smoking, blood pressure, diabetes mellitus, blood cholesterol and high density lipoproteins cholesterol. Separate score sheets are used for men and women.
The FR-score was evaluated for all subjects at enrollment, and we only include this baseline assessment in this analysis. Thus
for all observations. We considered gender and medication for hypertension as covariates that might have a substantial influence on the predictive accuracy of the FR-score. We fit the following models for the time dependent TPR and FPR functions: There is little loss to follow up in CHS. However, 487 subjects in the sample died from other causes without a cardiovascular failure. Rather than censoring these survival times at death which would imply that they were subsequently at risk for cardiovascular events, we censor them at the end of the is less than that on the FPR. This translates into the ROC curve for those on medication being less than for those who are not on medication, as illustrated in Figure 2 . In other words, the FR-score is better at distinguishing between subjects who will and will not have a cardiovascular event when they are not on medication. We have noted that given the same false positive rate, the corresponding true positive rate is substantially higher in females than in males. As shown in Table 2 ) lower than that in subjects not on medication (for both male and female) at year 1.
Perhaps the most important and disappointing result of our analysis however is that the FR-score is a very inaccurate marker for cardiovascular events. The ROC curves in Figure 2 demonstrate that the benefit of a high TPR can only be achieved at the expense of an accompanying high FPR and vice versa. It does not have adequate sensitivity and specificity (at any threshold) for accurate individual level prediction of cardiovascular events. Figure 3 displays the estimated TPR functions for events at at H § year and § years after the FR-score is measured in male subjects who are not on hypertension medication. These curves indicate that for any positivity threshold £ , the sensitivity of the FR-score is higher for events that occur at 1 year after enrollment than at § years after enrollment. In particular for these men, the threshold criterion FR-score
which identifies 45% of subjects with events at year after enrollment, identifies only 36% of subjects with events at § years. The FPR functions for those still without events at years after enrollment is also shown in Figure 3 . Of those subjects, 30% also meet criterion that FPR-score . Shown also in Figure 4 are the non-parametric estimates (Heagerty et al, 2000) of the ROC curves using data from each subgroup.
The nonparametric estimates are reasonably close to the model based estimates suggesting that the assumed semi-parametric models are reasonable.
REMARKS
Statistical models for the joint analysis of longitudinal biomarkers and time to disease onset have been studied extensively in the past decade (e.g., Pawitan and Self, 1993; De Gruttola and Tu, 1994; Tsiatis, De Gruttola and Wulfsohn, 1995; Faucett and Thoams, 1996; Wulfsohn and Tsiatis 1997; Hogan and Laird, 1997; Hederson, Diggle and Dobson, 2000; Skates, Pauler and Jacobs, 2001; Wang and Taylor, 2001; Henderson, Diggle and Dobson, 2002) . See Hogan and Laird (1997) for discussion of two broad classes of models, namely selection models and pattern mixture models. Most of the existing methods in this area require parametric modeling of the marker process over time and a joint parametric model for the distribution of the event time. To induce models for the association between the marker and event time process, both mixture models and selection models rely on specification of distributional assumptions for random effects or latent stochastic processes. In contrast, we use marginal semiparametric models for the marker distribution given the event time and for the event time distribution.
The approach does not model marker processes and hence is more flexible. We estimate the regression parameters and the non-parametric baseline functions simultaneously based on estimating equations and incorporate censoring by integrating over time.
There are several directions in which the methodology proposed here should be enhanced. First, procedures to assess model fit and to assist in model selection need development. Although the models are semiparametric, there is an assumption that covariate effects are additive on the scale of the link function and we did not test the adequacy of this assumption in our data analysis. Second, we have restricted to time independent covariates. It would be of interest to generalize the models to include time varying covariates. This is straightforward if covariates are external but more complicated when covariates are internal in the sense defined by Kalbfleisch and Prentice (2002) . Third, we have restricted to biomarkers measured prior to the occurrence of the event. However in some applications, such as in infectious disease research, there would be interest in using the biomarker to detect the event as soon as possible after 0 . Fourth, we do not allow censoring of 0 to depend on the marker conditional on the covariates. To do so would induce bias into the estimated true and false positive rates, commonly referred to as 'verification bias' in the diagnostic testing literature (Begg and Greenes, 1983) . Studies that seek to evaluate the sensitivity and specificity of a marker should be designed so that follow up does not depend on the marker. However, extensions that relax this requirement somewhat could be possibly developed using inverse probability weighting for example (Robins et al, 1995) . Finally, our methods can be used to assess the relative performance of two markers. One would fit separate models for each of the markers and plot the induced ROC curves. Comparisons could then be made using AUC statistics for example. It would be interesting to explore this further with real data.
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It is easy to see that almost surely, which has a unique minimizer at ¥ ¥ ¥C (Newey and McFadden, 1994) . To this end, let
. It follows from strong law of large numbers that
, where 
